FOLH1 and neoplasm: Fernando Pastor et al. also showed that bi-specific oligonucleotide aptamer conjugates (4-1BB aptamer ligand-PSMA aptamer conjugates) can deliver costimulatory ligands to tumor cells in situ and enhance antitumor immunity [94].